Alzheimer Mechanisms and Therapeutic Strategies

Huang, Yadong, Mucke, Lennart·2012·Cell
DOI 10.1016/j.cell.2012.02.040

Cited by (1,007)

Items 1,001–1,007 of 1,007

  1. Down-Regulation of Mir-107 Worsen Spatial Memory by Suppressing SYK Expression and Inactivating NF-ΚB Signaling Pathway
    Wenjie Hu, Lin Wen, Fang Cao, Yexin Wang · 2018 · Current Alzheimer Research
  2. Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease
    Xia, Zhao-Di, Ma, Ruo-Xin, Wen, Jin-Feng, Zhai, Yu-Fei, Wang, Yu-Qi, Wang, Feng-Yun, Liu, Dan, Zhao, Xiao-Long, Sun, Bao, Jia, Pu et al. · 2023 · Journal of Alzheimer's Disease
  3. Additive nanomanufacturing of lab-on-a-chip fluorescent peptide nanoparticle arrays for Alzheimer’s disease diagnosis
    Sun, Leming, Fan, Zhen, Yue, Tao, Yin, Jun, Fu, Jianzhong, Zhang, Mingjun · 2018 · Bio-Design and Manufacturing
  4. Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model
    Reinitz, Felicia, Chen, Elizabeth Y, Nicolis di Robilant, Benedetta, Chuluun, Bayarsaikhan, Antony, Jane, Jones, Robert C, Gubbi, Neha, Lee, Karen, Ho, William Hai Dang, Kolluru, Sai Saroja et al. · 2022 · eLife
  5. Apolipoprotein J in Alzheimer’s disease: shedding light on its role with cell signaling pathway perspective and possible therapeutic approaches
    Moezzi, Seyed-Mohammad-Iman, Mozafari, Negin, Fazel-Hoseini, Seyed-Mostafa, Nadimi-Parashkoohi, Sadra, Abbasi, Hosein, Ashrafi, Hajar, Azadi, Amir · 2020 · ACS Chemical Neuroscience
  6. Commentary: the central lymphatic drainage in pharmacological, surgical and physical therapies of Alzheimer's disease
    Ren, Lixuan, Ye, Jianping · 2024 · Acta Pharmaceutica Sinica B
  7. Isogenic human stem cell models reveal mutation-dependent protective mechanisms of APOE3 Christchurch
    Frisch, Carlye, Baker, Lauren, Srinivasan, Gayathri, Mintah, Albert E., Leyasi, Salma, Pedroza, Morgan, Galyon, Brooke, Brafman, David A. · 2026 · Frontiers in Aging Neuroscience